最新发布

单周下跌3000元/吨!草甘膦怎么了?

         5月份,草甘膦市场上演“高位跳水”行情,全月价格由强转弱、持续走跌,下旬跌势加速、行情大幅破位,月度回调幅度十分可观。     …

关于咨询邮箱共性(热点)问题回复—药效方面

         问:拟登记甲霜灵·嘧菌酯颗粒剂,防治水稻苗床立枯病、烂秧病,施药方式为水稻播种前拌毒土撒施于苗床,该产品是否可以登记?     &nbsp…

鹤壁全丰拟建调环酸钙、烯效唑等年产750吨植调剂项目

         近日,鹤壁全丰生物科技有限公司年产750吨植物生长调节剂项目环境影响评价公众参与信息公示。        建设单位拟在鹤壁宝山经济技…

小麦茎基腐病科学用药防控技术培训班在河南滑县举办

         5月18~21日,全国农技中心在河南滑县举办“促壮苗农技百日行”系列活动——小麦茎基腐病科学用药防控技术培训。参训代表现场观…

联化科技:四大业务板块协同发力,全球化布局构筑增长新引擎

         5月25日晚间,联化科技披露投资者关系活动记录表。在当天举行的投资者关系活动中,联化科技展示了其2025年度的经营成果与未来战略蓝图。面对复杂的全球市场环境,公司正通过&l…

石河子大学与“黑能量”战略合作,推动创新成果本地化应用

         5月25日下午,“黑能量增产肥”对棉花产量品质影响及生理机制研究项目签约仪式在石河子大学隆重举行。该项目旨在通过产学研深度融合,探索和挖掘&ldqu…

Future Food Quick Bites: Silk Protein, Pee for the Planet & The Coffee Bean

Danone-owned dairy-free brand Silk has released a protein soy milk in Canada, featuring a whopping 18g of complete protein per 250ml serving – that equates to 7.2g per 100ml, more than double that of cow’s milk, and higher than the protein milk it sells in the US. It’s available at major retailers in 1.42-litre bottles in plain and chocolate flavours.

The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells

With the demand for organ transplants at an all-time high, it is no secret that we are currently in the midst of an organ shortage crisis. Fortunately, the biotech industry is working on innovative ways to solve this problem. In this article, we look at three promising techniques that could make for the future of organ transplants. 

iPES-Food Report Warns Trade Wars and Supply Chain Fragility Are Driving Global Food Insecurity

A new report from the International Panel of Experts on Sustainable Food Systems (iPES Food) argues that cascading geopolitical disruptions are exposing deep structural weaknesses in the global food system, and that governments must act now to reduce dependence on volatile international markets.

EU Opens Public Consultation on Biotech Act II, Targeting Industrial Fermentation and Biomanufacturing

The European Commission’s call for evidence on its proposed Biotech Act II has drawn responses from across the alternative protein and industrial biotech sectors, with companies urging clearer regulatory pathways for fermentation-derived ingredients, cultivated biomass, and precision fermentation ahead of the June 10 deadline.